1,796 Shares in CME Group Inc. (NASDAQ:CME) Acquired by Intellectus Partners LLC

Intellectus Partners LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,796 shares of the financial services provider’s stock, valued at approximately $396,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Y.D. More Investments Ltd purchased a new position in CME Group during the 2nd quarter worth approximately $36,000. McClarren Financial Advisors Inc. raised its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the period. Asset Dedication LLC lifted its stake in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its position in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares during the period. Finally, Bank & Trust Co acquired a new position in shares of CME Group in the 2nd quarter valued at about $76,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Oppenheimer lifted their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Citigroup increased their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Bank of America boosted their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $224.47.

Insider Transactions at CME Group

In other news, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.8 %

CME stock opened at $225.28 on Friday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $81.12 billion, a PE ratio of 23.69, a price-to-earnings-growth ratio of 5.26 and a beta of 0.55. The business’s 50-day simple moving average is $222.52 and its 200 day simple moving average is $210.26.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.25 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group’s dividend payout ratio is currently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.